IL4 and autoimmune disease: These results imply that IL-5 receptor signaling is a potential target for therapeutic intervention in patients with autoimmune diseases, and provide evidence for a novel antagonistic relationship between IL-4 and IL-5 in the function of FasL+ killer B cells.